225 related articles for article (PubMed ID: 18292287)
1. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.
Muzio M; Apollonio B; Scielzo C; Frenquelli M; Vandoni I; Boussiotis V; Caligaris-Cappio F; Ghia P
Blood; 2008 Jul; 112(1):188-95. PubMed ID: 18292287
[TBL] [Abstract][Full Text] [Related]
2. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
[TBL] [Abstract][Full Text] [Related]
3. Targeting B-cell anergy in chronic lymphocytic leukemia.
Apollonio B; Scielzo C; Bertilaccio MT; Ten Hacken E; Scarfò L; Ranghetti P; Stevenson F; Packham G; Ghia P; Muzio M; Caligaris-Cappio F
Blood; 2013 May; 121(19):3879-88, S1-8. PubMed ID: 23460614
[TBL] [Abstract][Full Text] [Related]
4. Activation of extracellular signal-regulated kinase through B-cell antigen receptor in B-cell chronic lymphocytic leukemia.
Kawauchi K; Ogasawara T; Yasuyama M
Int J Hematol; 2002 Jun; 75(5):508-13. PubMed ID: 12095152
[TBL] [Abstract][Full Text] [Related]
5. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
[TBL] [Abstract][Full Text] [Related]
6. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
[TBL] [Abstract][Full Text] [Related]
7. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
9. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells.
Efremov DG; Gobessi S; Longo PG
Autoimmun Rev; 2007 Dec; 7(2):102-8. PubMed ID: 18035318
[TBL] [Abstract][Full Text] [Related]
10. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
12. Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
Zurli V; Wimmer G; Cattaneo F; Candi V; Cencini E; Gozzetti A; Raspadori D; Campoccia G; Sanseviero F; Bocchia M; Baldari CT; Kabanova A
Blood; 2017 Nov; 130(18):2006-2017. PubMed ID: 28931525
[TBL] [Abstract][Full Text] [Related]
13. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells.
Vilen BJ; Burke KM; Sleater M; Cambier JC
J Immunol; 2002 May; 168(9):4344-51. PubMed ID: 11970976
[TBL] [Abstract][Full Text] [Related]
14. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
[TBL] [Abstract][Full Text] [Related]
15. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.
Packham G; Krysov S; Allen A; Savelyeva N; Steele AJ; Forconi F; Stevenson FK
Haematologica; 2014 Jul; 99(7):1138-48. PubMed ID: 24986876
[TBL] [Abstract][Full Text] [Related]
16. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
17. Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.
Mockridge CI; Potter KN; Wheatley I; Neville LA; Packham G; Stevenson FK
Blood; 2007 May; 109(10):4424-31. PubMed ID: 17255355
[TBL] [Abstract][Full Text] [Related]
18. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia.
Allsup DJ; Kamiguti AS; Lin K; Sherrington PD; Matrai Z; Slupsky JR; Cawley JC; Zuzel M
Cancer Res; 2005 Aug; 65(16):7328-37. PubMed ID: 16103084
[TBL] [Abstract][Full Text] [Related]
19. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
[TBL] [Abstract][Full Text] [Related]
20. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
Longo PG; Laurenti L; Gobessi S; Petlickovski A; Pelosi M; Chiusolo P; Sica S; Leone G; Efremov DG
Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
